| AASLD

DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasis

Read more about DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasis

Hong‐Zhong Zhou, Fan Li, Sheng‐Tao Cheng, Yong Xu, Hai‐Jun Deng, Da‐Yong Gu, Jin Wang, Wei‐Xian Chen, Yu‐Jiao Zhou, Min‐Li Yang, Ji‐Hua Ren, Lu Zheng, Ai‐Long Huang, Juan Chen – 8 October 2021

Reply

Read more about Reply

Femke H.C. Goeij, Andrea Schlegel, Philipp Dutkowski – 7 October 2021

A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients

Read more about A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients

Jieling Xiao, Jie Ning Yong, Cheng Han Ng, Nicholas Syn, Wen Hui Lim, Darren Jun Hao Tan, En Ying Tan, Daniel Huang, Raymond C. Wong, Nicholas W. S. Chew, Eunice Xiang Xuan Tan, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah – 7 October 2021 – The shift in the changing etiology of cirrhosis requiring liver transplantation (LT) has resulted in an increasing prevalence of coronary artery disease (CAD) that can potentially impact post‐LT outcomes.

Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand

Read more about Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand

Jess Howell, Avik Majumdar, Michael A. Fink, Mandy Byrne, Geoff McCaughan, Simone I. Strasser, Michael Crawford, Peter Hodgkinson, Katherine A. Stuart, Caroline Tallis, John Chen, Alan Wigg, Robert Jones, Bryon Jaques, Gary Jeffrey, Leon Adams, Michael C. Wallace, Stephen Munn, Ed Gane, Alex J.

Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study

Read more about Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study

Lanlan Chen, Hongqun Yang, Haitao Li, Chang He, Liu Yang, Guoyue Lv – 7 October 2021

Macrophage nuclear factor erythroid 2‐related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3–mediated RhoA/ROCK pathway in the ischemic liver

Read more about Macrophage nuclear factor erythroid 2‐related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3–mediated RhoA/ROCK pathway in the ischemic liver

Jianhua Rao, Jiannan Qiu, Ming Ni, Hao Wang, Peng Wang, Lei Zhang, Zeng Wang, Mu Liu, Feng Cheng, Xuehao Wang, Ling Lu – 7 October 2021

Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay

Read more about Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay

Vinay Sundaram, Rajiv Jalan – 7 October 2021

Reply

Read more about Reply

Alberto Calleri, Margherita Saracco, Fabrizia Pittaluga, Rossana Cavallo, Renato Romagnoli, Silvia Martini – 6 October 2021

GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis

Read more about GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis

Amit G. Singal, Nabihah Tayob, Anand Mehta, Jorge A. Marrero, Hashem El‐Serag, Qingchun Jin, Cristian Saenz de Viteri, Austin Fobar, Neehar D. Parikh – 6 October 2021

Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High‐Risk Donor Livers

Read more about Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High‐Risk Donor Livers

Hynek Mergental, Richard W. Laing, James Hodson, Yuri L. Boteon, Joseph A. Attard, Laine L. Walace, Desley A. H. Neil, Darren Barton, Andrea Schlegel, Paolo Muiesan, Manuel Abradelo, John R. Isaac, Keith Roberts, M. Thamara P. R. Perera, Simon C. Afford, Darius F. Mirza – 6 October 2021 – Normothermic machine perfusion (NMP) allows objective assessment of donor liver transplantability. Several viability evaluation protocols have been established, consisting of parameters such as perfusate lactate clearance, pH, transaminase levels, and the production and composition of bile.

Subscribe to